Development of innovative strategies, tools, technologies, and methods for diagnostics and surveillance of antimicrobial resistance (DISTOMOS)

开发用于诊断和监测抗菌药物耐药性的创新策略、工具、技术和方法 (DISTOMOS)

• 批准号: 487206
• 负责人: Tokuriki Nobuhiko
• 金额: $ 36.42万
• 依托单位: University of British Columbia
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2023
• 资助国家: 加拿大
• 起止时间: 2023-07-01 至 2026-07-01
• 项目状态: 未结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=487206&lang=en
• 关键词: Antibiotic Resistance; Antibiotic Resistance Survaillance; Bioinformatics; Gram Negative Pathogens; New Drug Resistance; Phenotypic Characterizations

The majority of current resistance problems encountered in clinical practice start with the mobilisation of antibiotic resistance genes (ARGs) from the environment into clinical pathogens. Therefore, the pace at which a novel antibiotic will face resistan

目前在临床实践中遇到的大多数耐药性问题都始于抗生素耐药性基因(ARGs)从环境到临床病原体的动员。因此，一种新型抗生素面临耐药性的速度